José Luis
Sastre Moral
Medical University of Lodz
Łódź, PoloniaPublications in collaboration with researchers from Medical University of Lodz (1)
2019
-
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
The Lancet Oncology, Vol. 20, Núm. 6, pp. 781-794